Abstract: A steaming system is for steaming food. The steaming system including a base component adapted for receiving fluid therein, the base component being adapted to cooperate with a steam generating apparatus configured to heat up said fluid to produce steam. The steaming system also includes at least one steaming component includes a steaming compartment adapted to contain food to be steamed, the at least one steaming component being operatively mounted on the base component and being in fluid communication therewith. The steaming system is operable in a steaming configuration where the components are stacked onto one another to allow circulation of steam from the base component to the steaming compartment. The steaming system is further operable in a storage configuration where the base component is contained within the steaming compartment.

Abstract: A steaming system is for steaming food. The steaming system including a base component adapted for receiving fluid therein, the base component being adapted to cooperate with a steam generating apparatus configured to heat up said fluid to produce steam. The steaming system also includes at least one steaming component includes a steaming compartment adapted to contain food to be steamed, the at least one steaming component being operatively mounted on the base component and being in fluid communication therewith. The steaming system is operable in a steaming configuration where the components are stacked onto one another to allow circulation of steam from the base component to the steaming compartment. The steaming system is further operable in a storage configuration where the base component is contained within the steaming compartment.

Abstract: A method for diagnosing the presence of hereditary spastic paraplegia (HSP) or predicting the risk of developing HSP in a human subject, comprising detecting the presence or absence of a defect in a gene encoding a polypeptide comprising the sequence of FIG. 9 (SEQ ID NO: 19), in a nucleic acid sample of the subject, whereby the detection of the defect is indicative that the subject has or is at risk of developing HSP.

Abstract: A method for diagnosing the presence of hereditary spastic paraplegia (HSP) or predicting the risk of developing HSP in a human subject, comprising detecting the presence or absence of a defect in a gene encoding a polypeptide comprising the sequence of FIG. 9 (SEQ ID NO: 19), in a nucleic acid sample of the subject, whereby the detection of the defect is indicative that the subject has or is at risk of developing HSP.

Abstract: A method for diagnosing the presence of hereditary spastic paraplegia (HSP) or predicting the risk of developing HSP in a human subject, comprising detecting the presence or absence of a defect in a gene encoding a polypeptide comprising the sequence of FIG. 9 (SEQ ID NO: 19), in a nucleic acid sample of the subject, whereby the detection of the defect is indicative that the subject has or is at risk of developing HSP.

Abstract: A method for diagnosing the presence of hereditary spastic paraplegia (HSP) or predicting the risk of developing HSP in a human subject, comprising detecting the presence or absence of a defect in a gene encoding a polypeptide comprising the sequence of FIG. 9 (SEQ ID NO: 19), in a nucleic acid sample of the subject, whereby the detection of the defect is indicative that the subject has or is at risk of developing HSP.

Abstract: A method for diagnosing the presence of hereditary spastic paraplegia (HSP) or predicting the risk of developing HSP in a human subject, comprising detecting the presence or absence of a defect in a gene encoding a polypeptide comprising the sequence of FIG. 9 (SEQ ID NO: 19), in a nucleic acid sample of the subject, whereby the detection of the defect is indicative that the subject has or is at risk of developing HSP.

Abstract: A method for diagnosing the presence of hereditary spastic paraplegia (HSP) or predicting the risk of developing HSP in a human subject, comprising detecting the presence or absence of a defect in a gene encoding a polypeptide comprising the sequence of FIG. 9 (SEQ ID NO: 19), in a nucleic acid sample of the subject, whereby the detection of the defect is indicative that the subject has or is at risk of developing HSP.